Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Paul Glat

Plastic Surgery Philadelphia, PA Medical Doctor

NPI 1487602157 CMS profile 339146

160 E Erie Ave Ste 101, Philadelphia, PA 19134

Open in the dashboard

General payments

$325,262

579 records reported · program years 2019–2024

Research payments

$116,037

Paid to them · 32 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$139,619 paid to institutions, not to them · program years 2019–2024

Through program year 2024, Paul Glat of Philadelphia, PA is reported in the CMS Open Payments database as having received $325,262 across 579 general payments and $116,037 in research payments paid to them. Separately, studies naming them as principal investigator received $139,619 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $13,969 22
2023 General $44,199 82
2022 General $75,225 125
2021 General $43,649 113
2021 Research $6,000 4
2020 General $64,894 70
2020 Research $56,000 13
2019 General $83,326 167
2019 Research $54,037 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Glat
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Paul Glat were reported at $0. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Paul Glat Plastic Surgery median Middle half National median
2019 $83,326 $371 $122–$1,483 $163
2020 $64,894 $158 $52–$438 $114
2021 $43,649 $249 $87–$752 $132
2022 $75,225 $274 $102–$793 $149
2023 $44,199 $299 $113–$891 $160
2024 $13,969 $361 $124–$1,062 $164
2025 $0 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Smith+Nephew, Inc. $124,762 260 payments
  2. Medline Industries, Inc. $42,308 18 payments
  3. Avita Medical Americas, LLC $38,369 14 payments
  4. Molnlycke Health Care US, LLC $25,215 10 payments
  5. TELA Bio, Inc. $22,466 31 payments
  6. Musculoskeletal Transplant Foundation Inc. $17,418 40 payments
  7. Organogenesis Inc. $7,015 7 payments
  8. Merz North America, Inc. $6,434 55 payments
  9. Vericel Corporation $5,855 4 payments
  10. PolarityTE, Inc. $5,271 3 payments
  11. Other $30,150 137 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $157,609 58 payments
  2. Consulting Fee $99,507 59 payments
  3. Food and Beverage $30,894 341 payments
  4. Travel and Lodging $25,840 114 payments
  5. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $4,000 1 payment
  6. Compensation for serving as faculty or as a speaker for a medical education program $4,000 1 payment
  7. Honoraria $2,500 1 payment
  8. Royalty or License $766 3 payments
  9. Entertainment $146 1 payment
Products named General payments · program years 2019–2024
  1. Santyl $50,804 98 payments
  2. COLLAGENASE SANTYL Pharma Products $50,421 82 payments
  3. OASIS Extra Cellular Matrix $43,169 55 payments
  4. Versajet $42,656 51 payments
  5. ACTICOAT 4" X 4" $42,386 45 payments
  6. Dermatology and Wound Care $41,175 7 payments
  7. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $20,483 25 payments
  8. Oasis Extra Cellular Matrix $18,592 28 payments
  9. COLLAGENASE SANTYL Pharma Product $18,117 42 payments
  10. RECELL $16,000 2 payments
  11. Other $163,493 353 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. PolarityTE, Inc. $102,037 31 payments
  2. Grifols Biologicals LLC $14,000 1 payment

Records

611 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record